ACRAL LENTIGINOUS MELANOMA
Clinical trials for ACRAL LENTIGINOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new ACRAL LENTIGINOUS MELANOMA trials appear
Sign up with your email to follow new studies for ACRAL LENTIGINOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy timing may boost melanoma outcomes
Disease control OngoingThis phase II trial studies whether giving the immunotherapy drug pembrolizumab both before and after surgery works better than after surgery alone for people with stage III-IV high-risk melanoma. About 313 participants will receive pembrolizumab either before and after surgery o…
Matched conditions: ACRAL LENTIGINOUS MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug shows promise in slowing advanced melanoma
Disease control OngoingThis study tests a drug called dinaciclib in 72 people with stage IV melanoma that has spread. The drug works by blocking enzymes that help cancer cells grow. The goal is to see if it can shrink tumors or slow the disease, and to check for side effects.
Matched conditions: ACRAL LENTIGINOUS MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 07, 2026 18:43 UTC